Profile data is unavailable for this security.
About the company
Voyageur Pharmaceuticals Ltd. is a Canadian company, which develops barium, iodine and carbon active pharmaceutical ingredients. The Company is focused on producing its own barium, iodine and fullerene minerals. The Company, through its subsidiaries, Voyageur Industrial Minerals Ltd. and Voyageur Minerals Inc., is engaged in acquiring, exploring and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada and the state of Utah, United States. Its properties include Jubilee Mountain, Falcon and Paradox Basin. It owns a 100% interest in two barium sulphate (barite) projects, including the Frances Creek and Pedley Mountain property. It holds interests in a high-grade iodine, lithium, and bromine brine project situated in Utah, United States. It owns a 100% interest in two battery mineral projects that is focused on copper/zinc development. Its pipeline products include SmoothX 2.0%, MultiX Thick, MultiX Thin, HDX, LDX, VY-101 and VY-103.
- Revenue in CAD (TTM)0.00
- Net income in CAD-1.40m
- Incorporated2008
- Employees--
- LocationVoyageur Pharmaceuticals LtdDome Tower 800, 333 7 Ave. S.W.CALGARY T2P 2Z1CanadaCAN
- Phone+1 (403) 923-5944
- Fax+1 (403) 508-2670
- Websitehttps://voyageurpharmaceuticals.ca/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Titan Medical Inc | 24.08m | 9.49m | 6.25m | 4.00 | 0.9404 | 0.9568 | 0.6413 | 0.2597 | 0.0583 | 0.0583 | 0.1961 | 0.0573 | 2.22 | -- | -- | 6,019,124.00 | 87.56 | -113.26 | 365.95 | -793.56 | -- | -- | 39.43 | -201.89 | -- | -- | 0.2166 | -- | -- | -- | 116.34 | -- | -12.72 | -- |
| Rakovina Therapeutics Inc | 0.00 | -2.54m | 6.29m | -- | -- | 1.45 | -- | -- | -0.0363 | -0.0363 | 0.00 | 0.062 | 0.00 | -- | -- | -- | -39.99 | -- | -41.40 | -- | -- | -- | -- | -- | -- | -62.64 | 0.2329 | -- | -- | -- | 49.44 | -- | -- | -- |
| Voyageur Pharmaceuticals Ltd | 0.00 | -1.40m | 6.92m | -- | -- | 4.62 | -- | -- | -0.0106 | -0.0106 | 0.00 | 0.0108 | 0.00 | -- | -- | -- | -65.72 | -74.47 | -93.49 | -120.92 | -- | -- | -- | -- | 0.1162 | -300.53 | 0.0271 | -- | -- | -- | 20.21 | -- | -11.81 | -- |
| Good Shroom Co Inc | 4.26m | -35.66k | 7.09m | -- | -- | 11.53 | -- | 1.66 | -0.0007 | -0.0007 | 0.0852 | 0.0121 | 2.57 | 6.04 | 7.33 | -- | -2.15 | -- | -5.42 | -- | 26.23 | -- | -0.8368 | -- | 1.01 | -4.80 | 0.0971 | -- | 160.30 | -- | 72.24 | -- | -- | -- |
| XORTX Therapeutics Inc | 0.00 | -2.95m | 7.21m | 3.00 | -- | 1.14 | -- | -- | -1.52 | -1.52 | 0.00 | 3.17 | 0.00 | -- | -- | -- | -24.19 | -35.42 | -26.94 | -40.37 | -- | -- | -- | -- | -- | -- | 0.0025 | -- | -- | -- | 72.04 | -- | 7.91 | -- |
